α-Synuclein interacts with the switch region of Rab8a in a Ser129 phosphorylation-dependent manner

Alpha-synuclein (αS) misfolding is associated with Parkinson's disease (PD) but little is known about the mechanisms underlying αS toxicity. Increasing evidence suggests that defects in membrane transport play an important role in neuronal dysfunction. Here we demonstrate that the GTPase Rab8a interacts with αS in rodent brain. NMR spectroscopy reveals that the C-terminus of αS binds to the functionally important switch region as well as the C-terminal tail of Rab8a. In line with a direct Rab8a/αS interaction, Rab8a enhanced αS aggregation and reduced αS-induced cellular toxicity. In addition, Rab8 - the Drosophila ortholog of Rab8a - ameliorated αS-oligomer specific locomotor impairment and neuron loss in fruit flies. In support of the pathogenic relevance of the αS-Rab8a interaction, phosphorylation of αS at S129 enhanced binding to Rab8a, increased formation of insoluble αS aggregates and reduced cellular toxicity. Our study provides novel mechanistic insights into the interplay of the GTPase Rab8a and αS cytotoxicity, and underscores the therapeutic potential of targeting this interaction.

[1]  E. Masliah,et al.  The many faces of α-synuclein: from structure and toxicity to therapeutic target , 2012, Nature Reviews Neuroscience.

[2]  Nathan A. Baker,et al.  Electrostatics of nanosystems: Application to microtubules and the ribosome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Barrachina,et al.  Abnormal alpha-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease. , 2004, Neurobiology of disease.

[4]  Michel Goedert,et al.  Identification of two distinct synucleins from human brain , 1994, FEBS letters.

[5]  J. Hardy,et al.  The genetics of Parkinson's syndromes: a critical review. , 2009, Current opinion in genetics & development.

[6]  S. Nakano,et al.  Expression of the endocytosis regulatory proteins Rab5 and Rabaptin-5 in glial cytoplasmic inclusions from brains with multiple system atrophy. , 2000, Clinical neuropathology.

[7]  Leon D. Segal,et al.  Functions , 1995 .

[8]  David G. Nicholls,et al.  Bioenergetic analysis of isolated cerebrocortical nerve terminals on a microgram scale: spare respiratory capacity and stochastic mitochondrial failure , 2009, Journal of neurochemistry.

[9]  E. Masliah,et al.  Phosphorylation of Synucleins by Members of the Polo-like Kinase Family* , 2009, The Journal of Biological Chemistry.

[10]  Leonidas Stefanis,et al.  α-Synuclein Overexpression in PC12 and Chromaffin Cells Impairs Catecholamine Release by Interfering with a Late Step in Exocytosis , 2006, The Journal of Neuroscience.

[11]  A. Davies,et al.  Induction of neuronal death by α‐synuclein , 2000, The European journal of neuroscience.

[12]  E. Martínez-Alonso,et al.  Golgi fragmentation is Rab and SNARE dependent in cellular models of Parkinson’s disease , 2012, Histochemistry and Cell Biology.

[13]  R. Barbour,et al.  Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease* , 2006, Journal of Biological Chemistry.

[14]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[15]  A. Fink,et al.  Role of Different Regions of α-Synuclein in the Assembly of Fibrils† , 2007 .

[16]  T. Outeiro,et al.  Alpha-synuclein: from secretion to dysfunction and death , 2012, Cell Death and Disease.

[17]  C. Dobson,et al.  Structure and properties of a complex of α-synuclein and a single-domain camelid antibody. , 2010, Journal of molecular biology.

[18]  C. Griesinger,et al.  Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  E. Masliah,et al.  α-Synuclein is phosphorylated in synucleinopathy lesions , 2002, Nature Cell Biology.

[20]  E. Waxman,et al.  Characterization of kinases involved in the phosphorylation of aggregated α‐synuclein , 2011, Journal of neuroscience research.

[21]  J. Troncoso,et al.  Accumulation of Toxic α-Synuclein Oligomer within Endoplasmic Reticulum Occurs in α-Synucleinopathy In Vivo , 2012, The Journal of Neuroscience.

[22]  S. Lindquist,et al.  The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. , 2008, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Kenney,et al.  Microtubule-associated Protein 1B Is a Component of Cortical Lewy Bodies and Binds α-Synuclein Filaments* , 2000, The Journal of Biological Chemistry.

[24]  S. Lindquist,et al.  The Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis , 2008, Proceedings of the National Academy of Sciences.

[25]  R. Beyer,et al.  Rab11a and HSP90 Regulate Recycling of Extracellular α-Synuclein , 2009, The Journal of Neuroscience.

[26]  V. Subramaniam,et al.  Dependence of α-synuclein aggregate morphology on solution conditions , 2002 .

[27]  V. Subramaniam,et al.  NMR of α‐synuclein–polyamine complexes elucidates the mechanism and kinetics of induced aggregation , 2004, The EMBO journal.

[28]  Ad Bax,et al.  Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy. , 2009, Journal of molecular biology.

[29]  W. Bender,et al.  A Drosophila model of Parkinson's disease , 2000, Nature.

[30]  J. Trojanowski,et al.  Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae. , 2007, Molecular biology of the cell.

[31]  Virgil L. Woods,et al.  Structure and properties of α-synuclein and other amyloids determined at the amino acid level , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M G Spillantini,et al.  Alpha-synuclein in Lewy bodies. , 1997, Nature.

[33]  H. Stenmark Rab GTPases as coordinators of vesicle traffic , 2009, Nature Reviews Molecular Cell Biology.

[34]  R. Zhai,et al.  Assaying Locomotor, Learning, and Memory Deficits in Drosophila Models of Neurodegeneration , 2011, Journal of visualized experiments : JoVE.

[35]  R. Goody,et al.  Chaperone-assisted production of active human Rab8A GTPase in Escherichia coli. , 2009, Protein expression and purification.

[36]  P. Novick,et al.  An internal domain of Exo70p is required for actin-independent localization and mediates assembly of specific exocyst components. , 2009, Molecular biology of the cell.

[37]  J. Trojanowski,et al.  Synucleins Are Developmentally Expressed, and α-Synuclein Regulates the Size of the Presynaptic Vesicular Pool in Primary Hippocampal Neurons , 2000, The Journal of Neuroscience.

[38]  S. Koyama,et al.  Authentically Phosphorylated α-Synuclein at Ser129 Accelerates Neurodegeneration in a Rat Model of Familial Parkinson's Disease , 2011, The Journal of Neuroscience.

[39]  P. Aebischer,et al.  Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo , 2013, Proceedings of the National Academy of Sciences.

[40]  Thomas C. Südhof,et al.  α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration , 2005, Cell.

[41]  S. Tenreiro,et al.  PLK2 Modulates α-Synuclein Aggregation in Yeast and Mammalian Cells , 2013, Molecular Neurobiology.

[42]  T. Iwatsubo,et al.  A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in alpha-synuclein transgenic C. elegans. , 2008, Human molecular genetics.

[43]  K. Chung,et al.  Induction of Neuronal Cell Death by Rab5A-dependent Endocytosis of α-Synuclein* , 2001, The Journal of Biological Chemistry.

[44]  M. Feany,et al.  Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. , 2005, Nature neuroscience.

[45]  M. Feany,et al.  α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease , 2005, Nature Neuroscience.

[46]  T. Iwatsubo,et al.  Phosphorylation of α-Synuclein Protein at Ser-129 Reduces Neuronal Dysfunction by Lowering Its Membrane Binding Property in Caenorhabditis elegans* , 2012, The Journal of Biological Chemistry.

[47]  D. Lambright,et al.  Structural Mechanisms for Regulation of Membrane Traffic by Rab GTPases , 2009, Traffic.

[48]  Philippe Amouyel,et al.  α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[49]  D. Neill,et al.  Aggregates from mutant and wild‐type α‐synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β‐sheet and amyloid‐like filaments , 1998, FEBS letters.

[50]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[51]  C. Dobson,et al.  Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations. , 2005, Journal of the American Chemical Society.

[52]  Nikolaus R. McFarland,et al.  &agr;-Synuclein S129 Phosphorylation Mutants Do Not Alter Nigrostriatal Toxicity in a Rat Model of Parkinson Disease , 2009, Journal of neuropathology and experimental neurology.

[53]  S. Lindquist,et al.  α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models , 2006, Science.

[54]  R. Goody,et al.  GTPases involved in vesicular trafficking: structures and mechanisms. , 2011, Seminars in cell & developmental biology.

[55]  Fred H. Gage,et al.  In vivo demonstration that α-synuclein oligomers are toxic , 2011, Proceedings of the National Academy of Sciences.

[56]  Michele Vendruscolo,et al.  Amyloid-like Aggregates Sequester Numerous Metastable Proteins with Essential Cellular Functions , 2011, Cell.

[57]  M. Zweckstetter,et al.  Mars - robust automatic backbone assignment of proteins , 2004, Journal of biomolecular NMR.

[58]  Akihiko Iwai,et al.  The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system , 1995, Neuron.

[59]  R. Hawkins,et al.  α‐Synuclein produces a long‐lasting increase in neurotransmitter release , 2004, The EMBO journal.

[60]  B. Hyman,et al.  Interaction of alpha-synuclein and synphilin-1: effect of Parkinson's disease-associated mutations. , 2001, Journal of neurochemistry.

[61]  C. Dobson,et al.  Conserved C-terminal charge exerts a profound influence on the aggregation rate of α-synuclein. , 2011, Journal of molecular biology.

[62]  E. Masliah,et al.  alpha-Synuclein is phosphorylated in synucleinopathy lesions. , 2002, Nature cell biology.

[63]  Chul-hak Yang,et al.  Structural and functional implications of C-terminal regions of alpha-synuclein. , 2002, Biochemistry.

[64]  Virgil L. Woods,et al.  Structure and properties of alpha-synuclein and other amyloids determined at the amino acid level. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[65]  K. Brunden,et al.  Lewy Body-like α-Synuclein Aggregates Resist Degradation and Impair Macroautophagy*♦ , 2013, The Journal of Biological Chemistry.

[66]  E. Masliah,et al.  Suppression of α-synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context. , 2012, Human molecular genetics.

[67]  H. Jäckle,et al.  Pre‐fibrillar α‐synuclein variants with impaired β‐structure increase neurotoxicity in Parkinson's disease models , 2009, The EMBO journal.

[68]  Bradley T. Hyman,et al.  Formation of Toxic Oligomeric α-Synuclein Species in Living Cells , 2008, PloS one.

[69]  T. Südhof,et al.  Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. , 2005, Cell.

[70]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[71]  D. Eliezer,et al.  Conformational properties of alpha-synuclein in its free and lipid-associated states. , 2001, Journal of molecular biology.

[72]  Sara M. Butterfield,et al.  Amyloidogenic Protein—Membrane Interactions: Mechanistic Insight from Model Systems , 2010 .

[73]  M. Chesselet,et al.  In vivo alpha-synuclein overexpression in rodents: A useful model of Parkinson's disease? , 2008, Experimental Neurology.

[74]  Jorgensen,et al.  On the conformational properties of , 2000, The Journal of organic chemistry.

[75]  J. Baum,et al.  Detection of transient interchain interactions in the intrinsically disordered protein alpha-synuclein by NMR paramagnetic relaxation enhancement. , 2010, Journal of the American Chemical Society.

[76]  M. Cookson α-Synuclein and neuronal cell death , 2009, Molecular Neurodegeneration.

[77]  Normand L. Frigon,et al.  Polo-like Kinase 2 (PLK2) Phosphorylates α-Synuclein at Serine 129 in Central Nervous System*S⃞ , 2009, Journal of Biological Chemistry.

[78]  Ad Bax,et al.  Structure and Dynamics of Micelle-bound Human α-Synuclein* , 2005, Journal of Biological Chemistry.

[79]  Heidi Phillips,et al.  Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System , 2000, Neuron.

[80]  M. Barrachina,et al.  Abnormal α-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease , 2004, Neurobiology of Disease.

[81]  S E Ide,et al.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.

[82]  D. Selkoe,et al.  α‐Synuclein and Polyunsaturated Fatty Acids Promote Clathrin‐Mediated Endocytosis and Synaptic Vesicle Recycling , 2009, Traffic.

[83]  I. Forsythe,et al.  Rab11 rescues synaptic dysfunction and behavioural deficits in a Drosophila model of Huntington's disease , 2012, Human molecular genetics.

[84]  D. Sheff,et al.  Rab8 regulates basolateral secretory, but not recycling, traffic at the recycling endosome. , 2008, Molecular Biology of the Cell.

[85]  O. Isacson,et al.  Functional enhancement and protection of dopaminergic terminals by RAB3B overexpression , 2009, Proceedings of the National Academy of Sciences.

[86]  B. Hyman,et al.  α-Synuclein–enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons , 2001, Neuroscience.

[87]  Philippe Amouyel,et al.  Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. , 2004, Lancet.

[88]  P. Fraser,et al.  α-Synuclein Membrane Association Is Regulated by the Rab3a Recycling Machinery and Presynaptic Activity*♦ , 2013, The Journal of Biological Chemistry.

[89]  Chul-hak Yang,et al.  Structural and Functional Implications of C-Terminal Regions of α-Synuclein† , 2002 .

[90]  R. Goody,et al.  A structural basis for Lowe syndrome caused by mutations in the Rab‐binding domain of OCRL1 , 2011, The EMBO journal.

[91]  Ora Schueler-Furman,et al.  Rosetta FlexPepDock web server—high resolution modeling of peptide–protein interactions , 2011, Nucleic Acids Res..

[92]  E. Dalfo,et al.  α-Synuclein binding to rab3a in multiple system atrophy , 2005, Neuroscience Letters.

[93]  H. Jäckle,et al.  Pre-Fibrillar α-Synuclein Mutants Cause Parkinson's Disease-Like Non-Motor Symptoms in Drosophila , 2011, PloS one.

[94]  H. Lashuel,et al.  Provided for Non-commercial Research and Educational Use Only. Not for Reproduction, Distribution or Commercial Use. Author's Personal Copy Role of Post-translational Modifications in Modulating the Structure, Function and Toxicity of A-synuclein: Implications for Parkinson's Disease Pathogenesis an , 2022 .

[95]  A. Fink,et al.  Role of different regions of alpha-synuclein in the assembly of fibrils. , 2007, Biochemistry.

[96]  S. Lindquist,et al.  α-Synuclein: membrane interactions and toxicity in Parkinson's disease. , 2010, Annual review of cell and developmental biology.

[97]  Henning Stahlberg,et al.  The fold of α-synuclein fibrils , 2008, Proceedings of the National Academy of Sciences.

[98]  P. Højrup,et al.  α-Synuclein Binds to Tau and Stimulates the Protein Kinase A-catalyzed Tau Phosphorylation of Serine Residues 262 and 356* , 1999, The Journal of Biological Chemistry.

[99]  R. Nussbaum,et al.  Proteomics Analysis Identifies Phosphorylation-dependent α-Synuclein Protein Interactions *S , 2008, Molecular & Cellular Proteomics.

[100]  Nir London,et al.  Sub‐angstrom modeling of complexes between flexible peptides and globular proteins , 2010, Proteins.

[101]  C. Burd,et al.  Aggregation of α-Synuclein in S. cerevisiae is Associated with Defects in Endosomal Trafficking and Phospholipid Biosynthesis , 2011, Journal of Molecular Neuroscience.

[102]  V. Subramaniam,et al.  Dependence of alpha-synuclein aggregate morphology on solution conditions. , 2002, Journal of molecular biology.

[103]  D. Sulzer,et al.  Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. , 2000, Neuron.

[104]  D. Craik,et al.  Studies of protein-ligand interactions by NMR. , 1997, Methods in molecular biology.

[105]  Richard Paylor,et al.  Synaptic Vesicle Depletion Correlates with Attenuated Synaptic Responses to Prolonged Repetitive Stimulation in Mice Lacking α-Synuclein , 2002, The Journal of Neuroscience.

[106]  M. Feany,et al.  Parkinson's disease: Insights from non-traditional model organisms , 2010, Progress in Neurobiology.

[107]  P. Lansbury,et al.  Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.

[108]  I. Forsythe,et al.  Rab 11 rescues synaptic dysfunction and behavioural deficits in a Drosophila model of Huntington ’ s disease , 2012 .

[109]  E. Waxman,et al.  Molecular mechanisms of alpha-synuclein neurodegeneration. , 2009, Biochimica et biophysica acta.

[110]  W. Gibb Neuropathology of Parkinson's disease and related syndromes. , 1992, Neurologic clinics.

[111]  V. Subramaniam,et al.  Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro. , 2004, Biochemistry.

[112]  T. Südhof,et al.  α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro , 2010, Science.

[113]  V. Uversky,et al.  Polycation-induced oligomerization and accelerated fibrillation of human alpha-synuclein in vitro. , 2003, Protein science : a publication of the Protein Society.

[114]  T. Gómez-Isla,et al.  Abnormal alpha-synuclein interactions with Rab proteins in alpha-synuclein A30P transgenic mice. , 2004, Journal of neuropathology and experimental neurology.

[115]  Jennifer C. Lee,et al.  α-Synuclein Interacts with Glucocerebrosidase Providing a Molecular Link between Parkinson and Gaucher Diseases* , 2011, The Journal of Biological Chemistry.

[116]  S. Arawaka,et al.  The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson’s disease: a review of in vivo models , 2013, Reviews in the neurosciences.

[117]  B. Hyman,et al.  Interaction of α‐synuclein and synphilin‐1: effect of Parkinson's disease‐associated mutations , 2001 .

[118]  V. Uversky,et al.  Polycation‐induced oligomerization and accelerated fibrillation of human α‐synuclein in vitro , 2003 .

[119]  Markus Zweckstetter,et al.  Backbone assignment of proteins with known structure using residual dipolar couplings , 2004, Journal of biomolecular NMR.

[120]  The relation of hostile nonverbal communication styles to popularity in preadolescent children. , 1989, The Journal of genetic psychology.